IL308472A - Adenoviral helper plasmid - Google Patents
Adenoviral helper plasmidInfo
- Publication number
- IL308472A IL308472A IL308472A IL30847223A IL308472A IL 308472 A IL308472 A IL 308472A IL 308472 A IL308472 A IL 308472A IL 30847223 A IL30847223 A IL 30847223A IL 308472 A IL308472 A IL 308472A
- Authority
- IL
- Israel
- Prior art keywords
- helper plasmid
- adenoviral helper
- adenoviral
- plasmid
- helper
- Prior art date
Links
- 239000013612 plasmid Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10344—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163188294P | 2021-05-13 | 2021-05-13 | |
| PCT/US2022/029193 WO2022241215A2 (en) | 2021-05-13 | 2022-05-13 | Adenoviral helper plasmid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL308472A true IL308472A (en) | 2024-01-01 |
Family
ID=84029842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL308472A IL308472A (en) | 2021-05-13 | 2022-05-13 | Adenoviral helper plasmid |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250019667A1 (https=) |
| EP (1) | EP4337236A4 (https=) |
| JP (1) | JP2024518553A (https=) |
| KR (1) | KR20240036508A (https=) |
| CN (1) | CN117897167A (https=) |
| AU (1) | AU2022272316A1 (https=) |
| CA (1) | CA3218342A1 (https=) |
| IL (1) | IL308472A (https=) |
| WO (1) | WO2022241215A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4619018A2 (en) * | 2022-11-16 | 2025-09-24 | Forge Biologics, Inc. | Adenoviral helper plasmid |
| CN119842820A (zh) * | 2023-10-16 | 2025-04-18 | 深圳市深研生物科技有限公司 | 用于生产重组腺相关病毒载体的方法及包装/生产细胞 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223391A (en) * | 1990-02-21 | 1993-06-29 | President And Fellows Of Harvard College | Inhibitors of herpes simplex virus replication |
| US5543264A (en) * | 1990-06-29 | 1996-08-06 | Associated Universities, Inc. | Co-factor activated recombinant adenovirus proteinases |
| US6670188B1 (en) * | 1998-04-24 | 2003-12-30 | Crucell Holland B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
| AU2001257611A1 (en) * | 2000-04-28 | 2001-11-12 | Avigen, Inc. | Polynucleotides for use in recombinant adeno-associated virus virion production |
| US7754201B2 (en) * | 2000-06-02 | 2010-07-13 | GenPhar, Inc | Method of vaccination through serotype rotation |
| EP2336339A3 (en) * | 2000-09-25 | 2011-09-14 | The Regents of the University of Michigan | Production of viral vectors |
| US20040197347A1 (en) * | 2002-09-23 | 2004-10-07 | Board Of Regents, The University Of Texas System | Methods for vaccine identification and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the herpesvirus family |
| WO2004083418A1 (en) * | 2003-03-17 | 2004-09-30 | Merck & Co., Inc. | Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby |
| US20050118683A1 (en) * | 2003-06-11 | 2005-06-02 | Wood Clive R. | Method for producing a polypeptide |
| US20080063656A1 (en) * | 2004-08-09 | 2008-03-13 | Emini Emilio A | Adenoviral Vector Compositions |
| CN103436507B (zh) * | 2006-05-05 | 2016-04-20 | 冈戈根股份有限公司 | 噬菌体衍生的抗微生物活性剂 |
| EP2463362B1 (en) * | 2007-11-28 | 2017-11-08 | The Trustees Of The University Of Pennsylvania | Simian subfamily c adenovirus SAdv-31 and uses thereof |
| WO2010115172A2 (en) * | 2009-04-03 | 2010-10-07 | University Of Washington | Antigenic peptide of hsv-2 and methods for using same |
| US20120171191A1 (en) * | 2009-05-26 | 2012-07-05 | Cellectis | Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof |
| US20110293511A1 (en) * | 2009-09-29 | 2011-12-01 | Terrance Grant Johns | Specific binding proteins and uses thereof |
| WO2018017925A1 (en) * | 2016-07-22 | 2018-01-25 | President And Fellows Of Harvard College | Targeting lytic and latent herpes simplex virus 1 infection with crispr/cas9 |
| KR102652494B1 (ko) * | 2017-07-18 | 2024-03-28 | 제노비에 에이비 | 전장 t-세포 수용체 오픈 리딩 프레임의 신속한 조립 및 다양화를 위한 2-성분 벡터 라이브러리 시스템 |
| US12370269B2 (en) * | 2018-03-02 | 2025-07-29 | University Of Florida Research Foundation, Incorporated | Retinal protective factor 2 (RPF2) protein delivered by adeno-associated virus expression |
| EP3784785A4 (en) * | 2018-04-23 | 2022-02-16 | Duke University | DOWNREGULATION OF SNCA EXPRESSION BY TARGETED EDITING OF DNA METHYLATION |
| US20210324415A1 (en) * | 2018-10-09 | 2021-10-21 | Nikegen, Llc | Compositions and methods for preparing viral vectors |
| GB201816919D0 (en) * | 2018-10-17 | 2018-11-28 | Glaxosmithkline Ip Dev Ltd | Adeno-associated viral vector producer cell lines |
| SG10201906637UA (en) * | 2019-07-17 | 2021-02-25 | Agency Science Tech & Res | Treatment/prevention of disease by linc complex inhibition |
| CN114761030A (zh) * | 2019-11-01 | 2022-07-15 | 休斯敦系统大学 | 具有诱导的抗肿瘤免疫的溶瘤病毒疗法 |
| US11130787B2 (en) * | 2020-06-11 | 2021-09-28 | MBF Therapeutics, Inc. | Alphaherpesvirus glycoprotein d-encoding nucleic acid constructs and methods |
-
2022
- 2022-05-13 CA CA3218342A patent/CA3218342A1/en active Pending
- 2022-05-13 IL IL308472A patent/IL308472A/en unknown
- 2022-05-13 AU AU2022272316A patent/AU2022272316A1/en active Pending
- 2022-05-13 EP EP22808405.9A patent/EP4337236A4/en active Pending
- 2022-05-13 CN CN202280042134.2A patent/CN117897167A/zh active Pending
- 2022-05-13 US US18/560,651 patent/US20250019667A1/en active Pending
- 2022-05-13 JP JP2023570161A patent/JP2024518553A/ja active Pending
- 2022-05-13 WO PCT/US2022/029193 patent/WO2022241215A2/en not_active Ceased
- 2022-05-13 KR KR1020237042905A patent/KR20240036508A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4337236A2 (en) | 2024-03-20 |
| KR20240036508A (ko) | 2024-03-20 |
| CA3218342A1 (en) | 2022-11-17 |
| JP2024518553A (ja) | 2024-05-01 |
| EP4337236A4 (en) | 2025-04-16 |
| CN117897167A (zh) | 2024-04-16 |
| AU2022272316A1 (en) | 2023-11-30 |
| WO2022241215A3 (en) | 2023-02-02 |
| US20250019667A1 (en) | 2025-01-16 |
| WO2022241215A2 (en) | 2022-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287100A (en) | Plasmid system | |
| IL320727A (en) | Adenoviral helper plasmid | |
| PL3722434T3 (pl) | Układ plazmidowy | |
| GB202003618D0 (en) | Gene Therapy | |
| GB201905301D0 (en) | Gene therapy | |
| IL308472A (en) | Adenoviral helper plasmid | |
| IL290356A (en) | Formulations for Resotide | |
| GB201915094D0 (en) | New formulations | |
| GB202117828D0 (en) | New formulations | |
| GB201904338D0 (en) | Fluorouracil-containing formulations | |
| GB202100353D0 (en) | Aerosolizable nicoltine-containing formulations | |
| GB202100324D0 (en) | Blower | |
| IL287186B2 (en) | Monitoring gene therapies | |
| PT3911298T (pt) | Formulações | |
| CA188810S (en) | Electric wheelchair | |
| EP4347850A4 (en) | Novel dual helper plasmid | |
| GB2581811B (en) | Electric wheelchair | |
| GB2617817B (en) | Releasable connection means | |
| CA210361S (en) | Spatula | |
| CA3272427A1 (en) | Adenoviral helper plasmid | |
| GB202009684D0 (en) | Formulations | |
| GB202002202D0 (en) | Gene therapy | |
| GB201910092D0 (en) | New formulations | |
| HK40104650A (en) | Novel dual helper plasmid | |
| IL277696A (en) | Gene therapy for oxidative stress |